ARQT Arcutis Biotherapeutics, Inc. - Common stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 5, 2026
$25,16
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$19,30minimo 52 sett.
$31,77massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$3.16B
P/E (TTM)
114.4
EPS (TTM)
$0.22
Ricavi (TTM)
$464M
i tuoi badge
Intervallo 52 sett.
$19–$32
Rating Analisti
BUY
Prezzo Obiettivo
$37
P/E
114.4
ROE
15.9%
Margine di Profitto Netto
6.1%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
ARQT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$25.16
Capitalizzazione di Mercato (MRQ)
$3.16B
P/E (TTM)
114.4
EPS (TTM)
$0.22
Ricavi (TTM)
$464M
ROE (TTM)
15.9%
D/E Debito/Patrimonio (MRQ)
0.5
Intervallo 52 sett.
$19–$32
ARQT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$376M2020-12-31 → 2025-12-31
EPS$-0.132019-12-31 → 2025-12-31
Flusso di cassa libero$-6M2020-12-31 → 2025-12-31
Margine netto6.1%2023-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | ARQT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 114.4media 5 anni ≈-48.8 | ≈-48.8 | 27.9 | Sopravvalutato | |
| P/S (TTM) | 6.8media 5 anni ≈7.7 | ≈7.7 | 11.9 | Sottovalutato | |
| P/B (MRQ) | 14.3media 5 anni ≈10.9 | ≈10.9 | 4.9 | Sopravvalutato | |
| EV / EBITDA | -259.2media 5 anni ≈-104.4 | ≈-104.4 | · | · | |
| Prezzo / FCF (TTM) | 80.7media 5 anni ≈-194.5 | ≈-194.5 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 80.4media 5 anni ≈-217.5 | ≈-217.5 | · | · | |
| EV / Revenue (EV / Ricavi) | 8.4media 5 anni ≈8.5 | ≈8.5 | · | · | |
| EV / FCF | -502.2media 5 anni ≈-198.2 | ≈-198.2 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 15.3media 5 anni ≈8.7 | ≈8.7 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | ARQT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 7.4%media 5 anni ≈-157.7% | ≈-157.7% | 12.5% | In linea | |
| EBITDA Margin (Margine EBITDA) | -3.2%media 5 anni ≈-157.7% | ≈-157.7% | 12.5% | In linea | |
| Margine di Profitto Netto (TTM) | 6.1%media 5 anni ≈-171.8% | ≈-171.8% | 10.2% | In linea | |
| ROA (TTM) | 6.8%media 5 anni ≈-37.0% | ≈-37.0% | -13.8% | Di prim'ordine | |
| ROE (TTM) | 15.9%media 5 anni ≈-162.1% | ≈-162.1% | -10.7% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | ARQT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.5media 5 anni ≈1.2 | ≈1.2 | · | · | |
| Rapporto corrente (MRQ) | 2.9media 5 anni ≈4.8 | ≈4.8 | 4.6 | Bassa liquidità | |
| Quick Ratio | 1.5media 5 anni ≈1.9 | ≈1.9 | 4.1 | Bassa liquidità | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.5media 5 anni ≈1.2 | ≈1.2 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | ARQT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 91.3%media 5 anni ≈612.7% | ≈612.7% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 367.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | ARQT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 1.0media 5 anni ≈0.6 | ≈0.6 | 0.4 | Di prim'ordine | |
| Inventory Turnover (Rotazione delle scorte) | 2.0media 5 anni ≈1.3 | ≈1.3 | · | · | |
| Receivables Turnover (Rotazione dei crediti) | 3.4media 5 anni ≈3.6 | ≈3.6 | 8.4 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.1M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
56.7%
Prossimo report
Ott 26, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 4, 2026 | $0.11 | $0.04 | 150.6% |
| 31 Marzo 2026 | $-0.09 | $-0.08 | -7.4% | |
| 31 Dicembre 2025 | $0.13 | $0.12 | 12.4% | |
| 30 Settembre 2025 | $0.06 | $-0.10 | 158.9% | |
| 30 Giugno 2025 | $-0.13 | $-0.16 | 19.4% | |
| 31 Marzo 2025 | $-0.20 | $-0.21 | 6.6% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.54 | $1.34 | $0.92 | · | · | $6.24 | |
| Revenue / Share | $2.96 | $1.62 | $0.86 | · | · | · | |
| Cash Flow / Share | $-0.04 | $-0.93 | $-3.56 | · | · | · | |
| Cash / Share | $0.35 | $0.61 | $0.91 | · | · | $1.50 | |
| EPS (TTM) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | · | 127,623,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | · | 132,885,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.76 | $1.52 | · | $1.31 | $1.16 | $1.20 | · | $1.34 | $1.60 | · | · | $0.76 | · | · | · | $4.45 | |
| Revenue / Share | $0.96 | $814.73 | · | $0.75 | $0.64 | $0.52 | · | $0.36 | $0.25 | · | · | $0.62 | · | · | · | $0.01 | |
| Cash Flow / Share | · | $17.31 | · | · | · | $-0.24 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.28 | · | $0.39 | $0.61 | $0.45 | · | $1.15 | $0.72 | · | · | $1.74 | · | · | · | $1.34 | |
| EPS (TTM) | $0.22 | $-0.02 | · | $-0.36 | $-0.75 | $-1.04 | · | $-1.65 | $-2.05 | $-3.52 | · | $-4.39 | $-5.67 | $-5.78 | · | $-5.91 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $464M | $416M | · | $318M | $263M | $213M | · | $139M | $132M | $96M | · | $49M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $29M | $-2M | · | $-44M | $-93M | $-130M | · | $-196M | $-199M | $-231M | · | $-268M | $-326M | $-320M | · | $-311M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | 119.2 | -1178.0 | · | -52.4 | -18.7 | -15.0 | · | -5.6 | -4.5 | -2.8 | · | -1.2 | -1.7 | -1.9 | · | -3.2 | |
| P/S | 7.1 | 7.1 | · | 7.1 | 6.4 | 8.8 | · | 7.8 | 8.2 | · | · | 6.7 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 7.3 | 7.3 | · | 7.3 | 6.5 | 9.0 | · | 8.3 | 9.1 | · | · | 8.6 | · | · | · | 1764.4 | |
| Earnings Yield | 0.84% | -0.08% | · | -1.9% | -5.3% | -6.7% | · | -17.7% | -22.0% | -35.5% | · | -82.7% | -59.5% | -52.5% | · | -30.9% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $376M | $197M | $60M | $4M | $0 |
| Margine Operativo % | -3.2% | -65.3% | -404.5% | · | · |
| Utile netto | $-16M | $-140M | $-262M | $-311M | $-206M |
| EPS Diluito | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.6 | 0.7 | 2.3 | · | · |
| Rapporto corrente | 3.2 | 4.1 | 7.1 | · | · |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-6M | $-112M | $-247M | · | · |
Proprietari istituzionali (13F) 289 filer · $3.6B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
289
Valore detenuto
$3.6B
Nuove posizioni
39
Posizioni chiuse
33
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 39 (-4 vs trimestre precedente) | 33 (-9 vs trimestre precedente) | 93 (-10 vs trimestre precedente) | 101 (+13 vs trimestre precedente) | -1.9M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326.098.140 | 12.437.000 | 8,97% | Azioni |
| BlackRock, Inc. | $276.502.120 | 10.545.466 | 7,61% | Azioni |
| Frazier Life Sciences Management, L.P. | $258.909.678 | 9.874.511 | 7,12% | Azioni |
| Rubric Capital Management LP | $216.880.749 | 8.271.577 | 5,97% | Azioni |
| VANGUARD GROUP INC | $210.654.301 | 7.253.936 | 5,80% | Azioni |
| Polar Capital Holdings Plc | $173.234.098 | 6.606.945 | 4,77% | Azioni |
| STATE STREET CORP | $152.674.865 | 5.822.840 | 4,20% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $130.805.182 | 4.988.756 | 3,60% | Azioni |
| MORGAN STANLEY | $116.705.607 | 4.451.014 | 3,21% | Azioni |
| JENNISON ASSOCIATES LLC | $110.623.703 | 4.219.058 | 3,04% | Azioni |
| D. E. Shaw & Co., Inc. | $103.558.748 | 3.949.609 | 2,85% | Azioni |
| UBS Group AG | $87.391.654 | 3.333.015 | 2,40% | Azioni |
| BANK OF AMERICA CORP /DE/ | $78.330.441 | 2.987.431 | 2,16% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $78.214.092 | 2.982.446 | 2,15% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63.688.511 | 2.429.005 | 1,75% | Azioni |
| ORBIMED ADVISORS LLC | $53.541.240 | 2.042.000 | 1,47% | Azioni |
| FRANKLIN RESOURCES INC | $50.630.354 | 1.930.982 | 1,39% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $50.474.363 | 1.925.031 | 1,39% | Azioni |
| GOLDMAN SACHS GROUP INC | $43.744.582 | 1.668.367 | 1,20% | Azioni |
| JANUS HENDERSON GROUP PLC | $43.684.303 | 1.854.566 | 1,20% | Azioni |
| OBERWEIS ASSET MANAGEMENT INC/ | $35.998.513 | 1.372.941 | 0,99% | Azioni |
| GILDER GAGNON HOWE & CO LLC | $34.432.392 | 1.313.211 | 0,95% | Azioni |
| Pivotal bioVenture Partners Investment Advisor LLC | $33.175.720 | 1.265.283 | 0,91% | Azioni |
| BAMCO INC /NY/ | $32.856.806 | 1.253.120 | 0,90% | Azioni |
| CITADEL ADVISORS LLC | $30.415.567 | 1.160.014 | 0,84% | Azioni |
| FEDERATED HERMES, INC. | $29.487.772 | 1.124.629 | 0,81% | Azioni |
| Perpetual Ltd | $29.095.206 | 1.109.657 | 0,80% | Azioni |
| Aberdeen Group plc | $28.800.336 | 1.098.411 | 0,79% | Azioni |
| Jones Hill Capital LP | $28.571.960 | 1.089.701 | 0,79% | Azioni |
| NORTHERN TRUST CORP | $27.755.837 | 1.058.575 | 0,76% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27.555.489 | 1.050.934 | 0,76% | Azioni |
| Ensign Peak Advisors, Inc | $25.552.281 | 974.534 | 0,70% | Azioni |
| Candriam S.C.A. | $24.880.817 | 949.839 | 0,68% | Azioni |
| Driehaus Capital Management LLC | $23.032.330 | 878.426 | 0,63% | Azioni |
| Nuveen, LLC | $21.874.324 | 834.261 | 0,60% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $21.372.918 | 815.138 | 0,59% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21.284.137 | 811.752 | 0,59% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $17.406.855 | 663.877 | 0,48% | Azioni |
| FISHMAN JAY A LTD/MI | $15.601.031 | 595.005 | 0,43% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $14.789.968 | 564.072 | 0,41% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $14.349.629 | 547.278 | 0,39% | Azioni |
| Squarepoint Ops LLC | $14.099.726 | 537.747 | 0,39% | Azioni |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13.110.000 | 500.000 | 0,36% | Azioni |
| Nearwater Capital Markets, Ltd | $12.761.274 | 486.700 | 0,35% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.218.520 | 466.000 | 0,34% | Azioni |
| MARSHALL WACE, LLP | $11.716.827 | 446.866 | 0,32% | Azioni |
| Privium Fund Management B.V. | $10.471.403 | 399.367 | 0,29% | Azioni |
| NORGES BANK | $10.286.106 | 392.300 | 0,28% | Azioni |
| DEUTSCHE BANK AG\ | $10.033.923 | 382.682 | 0,28% | Azioni |
| Patient Square Capital LP | $9.701.400 | 370.000 | 0,27% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 depositi | 20 Agosto 2025 | 7,50% | Modifica | Investimento passivo | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 depositi | 26 Agosto 2022 | · | Deposito iniziale | · | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 depositi | 08 Agosto 2022 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 26 insider · 12 dirigenti · 14 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Todd Franklin Watanabe | Reporting Person's title: President and Chief Executive Officer | 03 Agosto 2026 S | 717.203 | 0 | 10 | $-4.439.604 |
| Latha Vairavan | SVP Chief Financial Officer | 11 Maggio 2026 S | 85.978 | 0 | 6 | $-148.496 |
| David Joseph Topper | Chief Financial Officer | 02 Aprile 2025 S | 182.774 | 0 | 0 | $0 |
| John W Smither | Chief Financial Officer | 13 Febbraio 2024 D | 11.365 | 0 | 0 | $0 |
| Scott L Burrows | Chief Financial Officer | 06 Marzo 2023 S | 59.115 | 0 | 0 | $0 |
| Masaru Matsuda | Reporting Person's title: EVP, Chief Legal Officer | 16 Settembre 2026 S | 112.508 | 0 | 18 | $-2.207.960 |
| Patrick Burnett | Reporting Person's title: EVP, Chief Medical Officer | 19 Agosto 2026 S | 117.592 | 0 | 18 | $-2.019.340 |
| Larry Todd Edwards | Reporting Person's title: EVP, Chief Commercial Officer | 27 Febbraio 2026 A | 175.178 | 0 | 6 | $-968.374 |
| Matthew Richard Moore | SVP and Chief Business Officer | 02 Maggio 2024 S | 145.505 | 0 | 0 | $0 |
| Kenneth A. Lock | Chief Commercial Officer | 06 Marzo 2023 S | 63.429 | 0 | 0 | $0 |
| Patricia A. Turney | SVP, Operations | 06 Marzo 2023 S | 62.862 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 06 Marzo 2023 S | 268.854 | 0 | 0 | $0 |
| Howard G. Welgus | Direttore | 15 Settembre 2026 M | 35.841 | 0 | 12 | $-2.236.210 |
| Terrie Curran | Direttore | 27 Agosto 2026 M | 23.526 | 0 | 3 | $-984.061 |
| Christopher Peetz | Direttore | 15 Luglio 2026 A | 4.315 | 0 | 0 | $0 |
| Sue-Jean Lin | Direttore | 15 Giugno 2026 S | 27.567 | 0 | 2 | $-898.455 |
| Neha Krishnamohan | Direttore | 05 Giugno 2026 A | 27.901 | 0 | 2 | $-939.510 |
| Amit Munshi | Direttore | 05 Giugno 2026 A | 9.799 | 0 | 0 | $0 |
| Halley E Gilbert | Direttore | 05 Giugno 2026 A | 27.901 | 0 | 1 | $-455.457 |
| Keith R Leonard | Direttore | 05 Giugno 2026 A | 27.901 | 0 | 1 | $-997.116 |
| Patrick J. Heron | Direttore | 05 Giugno 2026 A | 32.213 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Direttore | 12 Giugno 2025 A | 867.826 | 0 | 0 | $0 |
| Joseph L Turner | Direttore | 01 Giugno 2022 A | 4.312 | 0 | 0 | $0 |
| Jonathan Silverstein | Direttore | 02 Ottobre 2020 P | 902.286 | 0 | 0 | $0 |
| Daniel Estes | Direttore | 27 Febbraio 2020 A | · | 0 | 0 | $0 |
| Ricky Sun | · | 09 Giugno 2021 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 37 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| RZG · Invesco Exchange-Traded Fund Trust | 1,63% | 77.200 SH | 02 Ottobre 2026 | Giornaliero |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,58% | 108.697 SH | 02 Ottobre 2026 | Giornaliero |
| BBP · ETFis Series Trust I | 1,52% | 55.666 NS | 31 Luglio 2026 | N-PORT |
| GURU · Global X Funds | 1,46% | 33.313 NS | 31 Luglio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,54% | 98.745 NS | 31 Luglio 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,41% | 197.027 NS | 31 Luglio 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,38% | 61.480 SH | 02 Ottobre 2026 | Giornaliero |
| NUSC · Nushares ETF Trust | 0,22% | 107.502 NS | 31 Luglio 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,21% | 8.879 SH | 02 Ottobre 2026 | Giornaliero |
| IBB · iShares Trust | 0,19% | 842.985 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,18% | 122.691 SH | 19 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,18% | 1.074.467 SH | 11 Settembre 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,15% | 1.349 NS | 31 Luglio 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,13% | 66.540 NS | 31 Luglio 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,12% | 3.883 NS | 31 Luglio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 29.355 NS | 31 Luglio 2026 | N-PORT |
| RSSL · Global X Funds | 0,10% | 54.786 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 658.480 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,09% | 2.915.298 SH | 11 Settembre 2026 | Giornaliero |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 17.847 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,08% | 34.084 SH | 11 Settembre 2026 | Giornaliero |
| ESML · iShares Trust | 0,07% | 88.662 SH | 11 Settembre 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | 0,07% | 55.080 SH | 19 Agosto 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5.568 SH | 02 Ottobre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 53.372 NS | 31 Luglio 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 45.122 SH | 02 Ottobre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,04% | 335.913 SH | 19 Agosto 2026 | Giornaliero |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,03% | 24.688 SH | 02 Ottobre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.307.970 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,02% | 6.362 SH | 11 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,00% | 3.204 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.928 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 31.652 SH | 10 Settembre 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.565.928 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.521 SH | 19 Agosto 2026 | Giornaliero |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 2 SH | 02 Ottobre 2026 | Giornaliero |
| ISCB · iShares Trust | · | 4.781 SH | 11 Settembre 2026 | Giornaliero |
ARQT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 14 analisti
COMPRA
Target mediano
$38.00
+51,0%
4 28,6%
Acquisto forte
8 57,1%
Compra
2 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
7 analisti · 2026-10-01Target medio $37.00 +47,1%
← Sotto tutti i target
Prezzo attuale $25.16
Basso$34.00
Media$37.00
Alto$40.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 5, 2026